Cresco Labs (CRLBF) Other Non-Current Assets (2019 - 2026)

Cresco Labs (CRLBF) posted Other Non-Current Assets of $13.9 million for Q1 2026, down 1.58% on a QoQ basis from $14.1 million in Q4 2025, and down 17.91% year-over-year from $16.9 million in Q1 2025.

Cresco Labs (CRLBF) Other Non-Current Assets (2019 - 2026) Analysis & Trends

Cresco Labs' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $13.9 million for Q1 2026.

  • Quarterly Other Non-Current Assets fell 17.91% year-over-year to $13.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.9 million (down 17.91% YoY) and the FY2025 annual result came in at $14.1 million, down 5.94% from the prior year.
  • Other Non-Current Assets was $13.9 million for Q1 2026 at Cresco Labs, down from $14.1 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $22.9 million in Q3 2025 and bottomed at $4.2 million in Q1 2022.
  • A 5-year average of $10.5 million and a median of $9.4 million in 2022 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets plunged 36.64% — and 2025, when it surged 212.4%.
  • Cresco Labs' Other Non-Current Assets stood at $9.4 million in 2022, then plunged by 36.64% to $6.0 million in 2023, then jumped by 150.67% to $15.0 million in 2024, then decreased by 5.94% to $14.1 million in 2025, then retreated by 1.58% to $13.9 million in 2026.
  • Business Quant data shows CRLBF's Other Non-Current Assets at $13.9 million in Q1 2026, $14.1 million in Q4 2025, and $22.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Cresco Labs 254.96 Mn 99.57 Mn 75.45 Mn 13.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.88 Mn
Dec 31, 2025 14.10 Mn
Sep 30, 2025 22.90 Mn
Jun 30, 2025 13.90 Mn
Mar 31, 2025 16.90 Mn
Dec 31, 2024 14.99 Mn
Sep 30, 2024 7.33 Mn
Jun 30, 2024 7.57 Mn
Mar 31, 2024 7.71 Mn
Dec 31, 2023 5.98 Mn
Jun 30, 2023 4.98 Mn
Mar 31, 2023 9.92 Mn
Dec 31, 2022 9.44 Mn
Jun 30, 2022 4.22 Mn
Mar 31, 2022 4.21 Mn
Dec 31, 2021 4.21 Mn
Sep 30, 2021 4.14 Mn
Mar 31, 2021 3.91 Mn
Dec 31, 2020 3.71 Mn
Dec 31, 2019 62.11 Mn